HIGHLIGHTS
- who: ALT and collaborators from the Nanjing Second Hospital, China Chongqing Medical University, China have published the paper: TRAF2 as a key candidate gene in clinical hepatitis B-associated liver fi brosis, in the Journal: (JOURNAL)
- what: The aim of standardization was to remove technical and systematic variabilities from the data to compare the different samples. This study showed for the first time that patients with hepatic fibrosis in hepatitis B had considerably higher hepatic TRAF2 expression levels. The study showed that the lymphocyte-mediated immunomodulatory pathway TRAF2 was significantly elevated and ranked first in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.